Endothelial colony‐forming cell therapy for heart morphological changes after neonatal high oxygen exposure in rats, a model of complications of prematurity. Issue 22 (28th November 2018)

• Record Type: Journal Article
• Authors: Girard‐Bock, Camille; de Araújo, Carla C.; Bertagnolli, Mariane; Mai‐Vo, Thuy‐An; Vadivel, Arul; Alphonse, Rajesh S.; Zhong, Shumei; Cloutier, Anik; Sutherland, Megan R.; Thébaud, Bernard; Nuyt, Anne Monique
• Is Part Of: Physiological reports. Volume 6:Issue 22(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-11-28
• Subjects: Cell therapy -- heart -- oxygen‐induced cardiomyopathy -- preterm birth; Physiology -- Periodicals; 571
• DOI: 10.14814/phy2.13922
• Languages: English
• ISSNs: 2051-817X

Abstract

Abstract: Very preterm birth is associated with increased cardiovascular diseases and changes in myocardial structure. The current study aimed to investigate the impact of endothelial colony‐forming cell (ECFC) treatment on heart morphological changes in the experimental model of neonatal high oxygen (O2 )‐induced cardiomyopathy, mimicking prematurity‐related conditions. Sprague–Dawley rat pups exposed to 95% O2 or room air (RA) from day 4 (P4) to day 14 (P14) were randomized to receive (jugular vein) exogenous human cord blood ECFC or vehicle at P14 ( n = 5 RA‐vehicle, n = 8 RA‐ECFC, n = 8 O2 ‐vehicle and n = 7 O2 ‐ECFC) and the hearts collected at P28. Body and heart weights and heart to body weight ratio did not differ between groups. ECFC treatment prevented the increase in cardiomyocyte surface area in both the left (LV) and right (RV) ventricles of the O2 group (O2 ‐ECFC vs. O2 ‐vehicle LV: 121 ± 13 vs. 179 ± 21 μ m 2, RV: 118 ± 12 vs. 169 ± 21 μ m 2 ). In O2 rats, ECFC treatment was also associated with a significant reduction in interstitial fibrosis in both ventricles (O2 ‐ECFC vs. O2 ‐vehicle LV: 1.07 ± 0.47 vs. 1.68 ± 0.41% of surface area, RV: 1.01 ± 0.74 vs. 1.77 ± 0.67%) and in perivascular fibrosis in the LV (2.29 ± 0.47 vs. 3.85 ± 1.23%) but in not the RV (1.95 ± 0.95 vs. 2.74 ± 1.14), and with increased expression of angiogenesis marker CD31. ECFC treatment had no effect on cardiomyocyte surface area or on tissue fibrosis of RA rats. Human cord blood ECFC treatment prevented cardiomyocyte hypertrophy and myocardial and perivascular fibrosis observed after neonatal high O2 exposure. ECFC could constitute a new regenerative therapy against cardiac sequelae caused by deleterious conditions of prematurity. Abstract : Preterm birth and preterm birth‐related conditions are associated with changes in cardiac structure and function. The current study shows that endothelial colony‐forming cells treatment (ECFC, a subset of endothelial progenitor cells) after neonatal exposure to hyperoxia in rodents prevented myocardial tissue and perivascular fibrosis, cardiomyocyte hypertrophy, and was associated with increased CD31, a marker of angiogenesis. Considering the rapidly expanding field of regenerative medicine for prematurity‐related complications, these results suggest that pre‐clinical and clinical studies include cardiac outcomes in their measures.